Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
Diseases of the Respiratory Systems | COVID-19 Inpatient
What is the purpose of this trial?
The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens compared to standard of care (SOC), with respect to clinical status assessed by a 7-point ordinal scale on Day 11.
- Ages18 years and older
- Trial withGilead Sciences
- Start Date03/20/2020
- End Date05/30/2020
- Last Updated07/17/2020
- Study HIC#2000027734